Keywords = safety
Number of Articles: 17
1. Clinical Effectiveness of Erlova in EGFR-Mutated Non-Small Cell Lung Cancer: An Affordable Price with Clinical Benefit

Volume 23, Issue 4, April 2022, Pages 1155-1158

Sharareh Seifi; Babak Salimi; Zahra Esfahani-Monfared; Ramin Radmanesh; Saeed Yaghoubifard; Sara Talebianpour; Adnan Khosravi


2. Adverse Effects of Busulfan Plus Cyclophosphamide versus Busulfan Plus Fludarabine as Conditioning Regimens for Allogeneic Bone Marrow Transplantation

Volume 22, Issue 5, May 2021, Pages 1639-1644

Mahshid Mehdizadeh; Sayeh Parkhideh; Sina Salari; Abbas Hajifathali; Hamid Rezvani; Maryam Mabani


3. A Prospective Randomized Trial to Compare Safety, Acceptability and Efficacy of Thermal Ablation and Cryotherapy in a Screen and Treat Setting

Volume 21, Issue 5, May 2020, Pages 1391-1398

Dipanwita Banerjee; Ranajit Mandal; Amit Mandal; Ishita Ghosh; Srabani Mittal; Richard Muwonge; Eric Lucas; Partha Basu


4. The Efficacy and Safety of Modified Docetaxel, Cisplatin, and 5-Fluorouracil Vs. Epirubicin, Oxaliplatin, and Capecitabine Regimen in the Advanced Gastric Cancer: A Randomized Controlled Clinical Trial

Volume 21, Issue 3, March 2020, Pages 727-732

Ahmad Ahmadzadeh; Seyed Saeid Seyedian; Armita Valizadeh; Mahin Soleimani; Pedram Nazari; Hossein Hamidi


5. A Phase IV Efficacy Study of Formeta Plus Carboplatin as First-Line Treatment of Advanced Non-Squamous, Non-Small Cell Lung Cancer in Iran: An Affordable Price with Clinical Benefit

Volume 19, Issue 10, October 2018, Pages 2973-2978

Adnan Khosravi; Babak Salimi; Zahra Esfahani-Monfared; Sharareh Seifi; Hanifeh Mirtavoos-Mahyari